^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    NXE0039732

    i
    Other names: NXE0039732, HTL0039732, HTL-0039732, NXE-0039732, NXE'732, HTL’732
    Associations
    News
    Trials
    Company:
    Cancer Research UK, Nxera Pharma
    Drug class:
    PGE4 antagonist
    Related drugs:
    Associations
    News
    Trials